FEATURED EDITORIAL
By combining drugs/therapies with different mechanisms of action, different pathways in cancer cells can be targeted, potentially leading to improved patient outcomes. Using AI is hastening this research.
- Drug Design At The Speed Of Quantum
- EMA Issues Paper On Qualifying Non-Mutagenic Impurities For Drug Toxicological Safety
- 9 Reasons Why You Should Consider AI In Analytical Instrument Qualification
- What Do We (Really) Know About DNA Quality For In Vitro Transcription?
- FDA Issues Draft Guidance On The Use Of AI To Support Regulatory Decision-Making For Drug And Biological Products
- How Can 3D Bioprinting Advance Drug Discovery?
- Are Plant-Based APIs The Future Of Pharma And Nutraceuticals?
FEATURED APPLICATION CONTENT
-
Filtration is essential in various applications, from lab-scale tasks to GMP production, that removes contaminants to ensure safety and efficiency. Explore how its simplicity and reliability make it indispensable across industries.
-
In biologics manufacturing, change is constant. Discover how new innovations and a focus on sustainability have gotten 62% of executives to prioritize eco-friendly practices, which reflects a commitment to long-term viability.
-
T-cell therapies, including CAR-T and TCR, revolutionize cancer treatment by harnessing the immune system. Explore an efficient and scalable production process that helps meet crucial demand.
-
As cell therapies advance, challenges in ensuring safe, scalable, and compliant production increase. Discover how to develop efficient strategies to maintain cell viability and functionality throughout the supply chain.
-
Learn more about this cost-effective, efficient alternative to traditional Protein A resin chromatography for mAb production, enhancing productivity and reducing costs.
-
Efficiency in bioprocessing and achieving rapid mixing across various viscosities is crucial for consistent biopharmaceutical product quality. Discover more about the benefits of this mixer.
-
The repetitive nature of routine laboratory procedures can put technicians and scientists at risk for repetitive strain injury. Routine activities often include reoccurrence of the same movements over and over, which can take a toll on hands, wrists and shoulders and ultimately can lead to serious damage. Choosing the right tools can make all the difference.
-
Learn how Pierre Fabre Laboratories streamlined their antibody development with the implementation of a new platform, enabling efficient and multi-parameter stability measurements.
-
See how Cube Biotech and MIT researchers used dynamic light scattering (DLS) and nano differential scanning fluorimetry (nanoDSF) to find the best nanodisc conditions for three membrane proteins.
-
Membrane proteins are vital for drug discovery, but traditional techniques can disrupt their structure. This study showcases a new method that maintains native conformation during analysis.
-
Discover the ability of a novel HEK293 suspension cell line for efficient and scalable rAAV production across various serotypes with low encapsidated host cell DNA levels.
-
Discover strategies to overcome the challenges of nonclinical testing for pediatric and rare disease therapies, ensuring regulatory compliance and successfully advancing your medicinal products to the clinic.
FEATURED NEWS HEADLINES
- HiRO And Hallym University Sacred Heart Hospital Sign Strategic MOU To Advance Drug Development
- Alliance For Genomic Discovery Completes 250,000 Whole Genomes To Accelerate Drug Discovery
- Sapio Sciences Makes AI-Native Drug Discovery Seamless With NVIDIA BioNeMo
- Pharmacy Professor Lands Prestigious Grant To Advance Drug Discovery
- CUHK Develops Novel Drug Formulation Method That Increases Efficacy Of Drugs
- Helix Launches 23,000-Patient Clinico-Genomic Cohort For Autoimmune Diseases To Advance Drug Discovery And Development
- Valo Health And nference Announce Long-Term Partnership To Accelerate Human-Centric Drug Discovery And Development
- Precision BioSciences Announces Clearance Of Investigational New Drug Application By The U.S. FDA For First-In-Class PBGENE-HBV Designed To Eliminate Root Cause Of Chronic Hepatitis B
- Xeris Announces Approval Of Supplemental New Drug Application (sNDA) Of Gvoke VialDx (Glucagon) For Use As A Diagnostic Aid
- Taiho Pharmaceutical To Acquire Next-Generation ADC Drug Discovery Company Araris Biotech
ARCHIVED NEWSLETTER
- 03.20.25 -- Discover How To Optimize Productivity In Your mAb Capture
- 03.18.25 -- Your Go-To Guide For Ophthalmic Drug Development
- 03.18.25 -- EMA Issues Paper On Qualifying Non-Mutagenic Impurities For Drug Toxicological Safety
- 03.13.25 -- Optimize Your High Concentration Biologic Production Process
- 03.11.25 -- UTSA Chemist To Advance Drug Discovery Using Light To Activate Catalysts